From the Chief
"I am eager to come to work every day, because this is where groundbreaking discoveries and cures will come from."
News & Media
Transplant Changes Marlborough Woman's Life
Dr. Lawrence Brandt commented on his patient Shirley Fogge Piazza’s successful fecal transplant.
Cuervo Leads Panels at NIH Aging and Chronic Disease Symposium on Geroscience
The NIH has chosen Drs. Ana Maria Cuervo and Jeffrey Pessin to chair panels at the first symposium on "geroscience"—the study of how aging influences the onset of chronic diseases.
Zheng Receives Emerging Liver Scholar Resident Travel Award
Mentored by Dr. Allan Wolkoff, third-year resident Elizabeth Zheng was awarded an American Association of Liver Diseases (AASLD) Emerging Liver Scholar Resident Travel Award.
Scientists Identify 'Clean-Up' Snafu that Kills Brain Cells in Parkinson's Disease
Dr. Ana Maria Cuervo has discovered why toxic clumps of proteins accumulate in brain cells of those with a familial form of Parkinson's disease.
Nature interviewed Lawrence Brandt, M.D., about the first randomized clinical trial on using fecal transplants to treat recurring infections of Clostridium difficile, a bacterium that causes severe diarrhea. While the standard antibiotic treatment cured 27% of patients in the trial, fecal transplants cured 94%. Dr. Brandt, professor of medicine and of surgery at Einstein and emeritus chief of gastroenterology at Montefiore Medical Center, leads a blinded trial in which patients are treated with their own feces or those from healthy donors. (Thursday, January 17, 2013)
More coverage on this story
The New York Times
Los Angeles Times
Wolkoff Receives Distinguished Scientific Achievement Award
Dr. Allan Wolkoff, Chief of the Division of Gastroenterology and Liver Diseases at Einstein and Montefiore, and Professor of Medicine and Anatomy & Structural Biology at Einstein, received the 2012 Distinguished Scientific Achievement Award from the American Liver Foundation. This award is among the Foundation’s most prestigious honors and recognizes a scientist who has made a major contribution to the study of liver pathobiology and the prevention, treatment, or cure of liver disease.
Einstein On: Liver Disease, Dr. Allan Wolkoff
Allan W. Wolkoff, M.D., discusses liver disease and current research that could ultimately lead to new treatments.
The Washington Post quotes Dr. Lawrence Brandt regarding new guidelines for managing irritable bowel syndrome (IBS). Dr. Brandt is professor of medicine and of surgery at Einstein, and chief of gastroenterology at Montefiore Medical Center. (Thursday, December 18, 2008) read more...
An abstract co-authored by Dr. Lawrence Brandt and chief resident Dr. Olga Aroniadis (Gastroenterology & Liver Diseases) and submitted for presentation to the American College of Gastroenterology at its annual meeting won one of the five Governors' Awards for Excellence in Clinical Research. The abstract will be presented at the plenary session during the meeting in late October. Mellow, M, Kanatzar A, Brandt L , Aroniadis O, Kelly C, Stollman N, Rohlke F, Surawicz, C. Longterm Follow up of Colonoscopic Fecal Bacteriotherapy for Recurrent C. difficile Infection.
Dr. Paul Gaglio (Gastroenterology & Liver Diseases) was honored by the American Liver Foundation Greater New York Division on September 27th at its annual gala. Founded in 1997, the American Liver Foundation Greater New York Division serves New York State and Northeastern New Jersey, providing services including support groups, liver wellness education programs, a national helpline, fundraising events, and volunteer opportunities. The Division has successfully served thousands of liver disease patients and their families. See the American Liver Foundation website for more information.